Overview

A Study of Rofecoxib Versus Naproxen in the Treatment of Chinese Patient With Rheumatoid Arthritis (0966-231)

Status:
Completed
Trial end date:
2004-09-19
Target enrollment:
Participant gender:
Summary
A study to compare rofecoxib versus naproxen in the treatment of Chinese patients with rheumatoid arthritis.
Phase:
Phase 4
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Naproxen
Rofecoxib